MedPath

Pilot Study of Nutrition in Maintenance Hemodialysis Patients

Not Applicable
Completed
Conditions
End-Stage Renal Disease
Meals
Hemodialysis
Interventions
Dietary Supplement: Meals
Registration Number
NCT02917278
Lead Sponsor
Purdue University
Brief Summary

This pilot study aims to produce preliminary data on the safety of providing high-protein meals to patients during dialysis, and effects of this intervention on nutritional status and quality of life outcomes. This is a non-randomized, parallel arm study. Meals provided will follow recommended dietary guidelines for HD patients and will provide approximately 1/3 of daily recommended protein intake. Patients will be allocated to either the treatment or control group by HD shift schedule. 2 months of baseline data will be collected, followed by 9 weeks of meal intervention/control and data collection. The primary outcome will be frequency of hypotensive events during dialysis requiring intervention. Secondary outcomes will include highest and lowest systolic blood pressure during dialysis, blood biochemistries including measures of renal function, nutritional status, and electrolyte balance; dialysis compliance; fluid retention; sleep and other quality of life measures; and dietary intake data.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
19
Inclusion Criteria
  • Men and women
  • Any race
  • Age 18 years or older
  • Maintenance hemodialysis patients
Exclusion Criteria

• Patients with dysphagia that cannot be accommodated by texture modifications, or those exclusively NPO/requiring tube feeding or parenteral feeding

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MealsMealsHigh-protein renal-specific meals
Primary Outcome Measures
NameTimeMethod
Hypotensive Event Frequency9 weeks

frequency of hypotensive events that require intervention during dialysis

Secondary Outcome Measures
NameTimeMethod
Serum Sodium9 weeks
Hunger Rating9 weeks

Hunger rating on a visual analog scale of 0-10 cm. Higher values mean a better outcome.

Mean Arterial Pressure (mm Hg)9 weeks

Average Lowest Mean Arterial Pressure (mm Hg) over 25 dialysis sessions during the study.

Serum Albumin9 weeks
Blood Urea Nitrogen9 weeks
Serum Pre-albumin9 weeks
Dialysis Absences9 weeks

Absences out of 25 sessions

Serum Phosphate9 weeks
Vitality Score9 weeks

Vitality measured by SF-36 (Short Form 36 Health Survey) Questionnaire. Minimum-Maximum values 0-100, with higher scores meaning better outcomes.

Serum Creatinine9 weeks
Serum Chloride9 weeks
Serum CO29 weeks
Sleep Problems Index9 weeks

Sleep Problems Index-II from the Medical Outcomes Study (MOS) Sleep Scale. Minimum-Maximum values 0-100, with higher scores meaning better outcomes.

Blood Glucose9 weeks
Serum Adjusted Calcium9 weeks
Interdialytic Weight Gain9 weeks

Trial Locations

Locations (1)

Purdue University

🇺🇸

West Lafayette, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath